AVEO - AVEO Pharmaceuticals Inc
Close
15
0 0%
Share volume: 0
Last Updated: Thu 19 Jan 2023 10:00:01 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$15.00
0.00
0.00%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | |
Report Date | 2022-05-05 | 2022-08-04 | 2022-11-07 | |
Total revenue | 20.920 M | 25.304 M | 30.449 M | |
Cost of revenue | 2.434 M | 3.065 M | 3.964 M | |
Gross profit | 18.486 M | 22.239 M | 26.485 M | |
20.30% | 19.09% | |||
Operating expenses | 27.497 M | 29.393 M | 28.653 M | |
Selling general and admin | 17.337 M | 17.075 M | 17.579 M | |
Research and development | 10.160 M | 12.318 M | 11.074 M | |
Total expenses | 29.931 M | 32.458 M | 32.617 M | |
8.44% | 0.49% | |||
Operating income | -9.011 M | -7.154 M | -2.168 M | |
Ebit | -9.011 M | -7.154 M | -2.168 M | |
Pretax income | -10.199 M | -8.319 M | -3.266 M | |
-18.43% | -60.74% | |||
Income tax | 0.000 | 0.000 | 0.000 | |
Net income basic | -10.199 M | -8.319 M | -3.266 M | |
18.43% | 60.74% | |||
Net income | -10.199 M | -8.319 M | -3.266 M | |
18.43% | 60.74% |